ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

ZRANB1 enhances stem-cell-like features and accelerates tumor progression by regulating Sox9-mediated USP22/Wnt/β-catenin pathway in colorectal cancer

Miao, Dazhuang; Wang, Yan; Jia, Yunhe*; Tong, Jinxue*; Jiang, Shixiong; Liu, Lixiu哈尔滨医科大学
Cellular Signalling2022-2DOI: 10.1016/j.cellsig.2021.110200
12被引7阅读
引用收藏
分享

摘要

The pathogenesis of colorectal cancer (CRC) is a multistep process characterized by the accumulation of gene mutations and epigenetic alterations. Tumor necrosis factor receptor-associated factor-binding protein domain (ZRANB1) is a deubiquitinase that mediates tumor growth and metastasis by deubiquitinating target proteins. In this study, we examined the regulatory effects of ZRANB1 on the maintenance of cancer stem cell (CSC) properties and tumor growth in CRC. Human CRC tissue samples and matched normal tissues were collected for the analysis of ZRANB1 expression. ZRANB1 was upregulated in CRC human tissues and cell lines, and its expression was positively correlated with advanced tumor stage and poor survival of CRC patients. The overexpression of ZRANB1 also induced the expression of CSC markers in CRC cells. Then, a xenograft model was established by inoculating BALB/c mice with CRC cells. The upregulation of ZRANB1 promoted tumorigenesis in vivo. Sox9 is a transcription factor that acts as an oncogene in human cancers. ZRANB1 increased the stability of Sox9 in CRC cells by decelerating its ubiquitination. Further analysis revealed that Sox9 regulated the transcription activity of USP22 by binding to its promoter. Moreover, ZRANB1 enhances stem-cell-like features of CRC cells and activated the Wnt/beta-catenin pathway through USP22. Our results highlighted the role of ZRANB1 as a molecular target for CRC treatment, which may contribute to the development of novel therapies with better efficacy.

学科与关键词

关键词
ZRANB1Sox9USP22Wnt/beta-cateninColorectal cancer
相关
加载中…
  • CDC Like Kinase 2 plays an oncogenic role in colorectal cancer via modulating the Wnt/β-catenin signaling
    Zhou, Hai-Bo; Yang, Li; Liu, Shi-Fang; Xu, Xin-Hua; Chen, Zhuo; LI, Yun-Xiao; Yuan, Jin-Hua*; Wei, Yong-Chang*Neoplasma, 2022, 69(3): 657-+.被引 5
  • DEPDC1B promotes colorectal cancer via facilitating cell proliferation and migration while inhibiting apoptosis
    Han, Fei; Cheng, Chao; Xu, Qianqian; Chen, Jisong; Yang, Zhaohui*; Liu, Jun*CELL CYCLE, 2023, 22(1): 131-143.被引 4
  • SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer
    Zhu, Yin; Huang, Shimiao; Chen, Shengyuan; Chen, Jiaxuan; Wang, Zhiqing; Wang, Yadong; Zheng, Haoxuan*Cell Death & Disease, 2021, 12(5): 449.被引 67
查看全部 →

发表信息

论文状态
公开发表
期刊
Cellular Signalling
发表日期
2022-02
卷期
第 90 卷
页码
110200
DOI
10.1016/j.cellsig.2021.110200
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
Basic Scientific Research Operating Expenses of Provincial Institutions of Higher Learning in Heilongjiang Province [2019-KYYWF-0358]; Haiyan Research Fund of Harbin Medical University Cancer Hospital [JJZD2021-05]; Research Fund of Beijing Medical Award Foundation [YXJL2020-1223-0320]; Scientific Research Fund of Heilongjiang Health Commission [2020-069]; Wu Jieping Medical Foundation [320.6750.2021-2-23]

作者

  • M

    Miao, Dazhuang (第一作者)

    2 · harbin med univ

  • W

    Wang, Yan

    2 · harbin med univ

查看全部 6 位作者收起作者
  • J

    Jia, Yunhe (通讯)

    2 · harbin med univ

  • T

    Tong, Jinxue (通讯)

    2 · harbin med univ

  • J

    Jiang, Shixiong

    2 · harbin med univ

  • L

    Liu, Lixiu

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417